PTGS2 and colorectal cancer: Up to now, the reports from basic and clinical investigations have shown that inhibition of PGE2 synthesis by specific COX-2 inhibitors, for example, nonsteroidal anti-inflammatory drugs (NSAIDs) may decrease the risk and improve prognosis of carcinogenesis of various types of cancer including colorectal cancer 64, 114-120.